Importantly, in the most recent research, luteolin has been proven to suppress the matrix stiffness-induced biological effects and the CXCR4-mediated yes-associated protein (YAP) signaling pathway in hepatocellular carcinoma (HCC) cells. The gene discussed is CXCR4; the disease is hepatocellular carcinoma.